Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “monoclonal”

203 pharma patents match "monoclonal" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 203
Index total 30,257
Page 1 / 9

Quick answer

This filtered view shows 203 pharmaceutical patents matching "monoclonal" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

203 results for “monoclonal” · 30,257 patents in full index Clear search

  1. US 12415866

    Monoclonal antibody inhibitor of Factor XIIa

    Takeda Pharmaceutical Company Limited · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  2. US 12358971

    Arena virus monoclonal antibodies and uses

    The Boad of Regents of the University of Texas System · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  3. US 12344676

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  4. US 12331110

    Monoclonal antibodies against endotrophin and the use thereof

    The Board of Regents of the University of Texas System · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  5. US 12275781

    Monoclonal antibodies against MHC-bound human dickkopf-1 peptides and uses thereof

    The Board of Regents of the University of Texas System · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  6. US 12152071

    EGFL6 specific monoclonal antibodies and methods of their use

    The Board of Regents of the University of Texas System · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  7. US 12122843

    High affinity monoclonal antibodies targeting glypican-1 and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 22, 2024 · Expires Oct 17, 2044

    granted
  8. US 12077572

    Monoclonal antibody for spike protein of middle east respiratory syndrome coronavirus, and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 3, 2024 · Expires Aug 29, 2044

    granted
  9. US 12037401

    Anti-TrkB monoclonal antibodies and methods of use

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  10. US 12012463

    High affinity monoclonal antibodies targeting glypican-2 and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 18, 2024 · Expires Jun 13, 2044

    granted
  11. US 12012455

    Human monoclonal antibodies specific for FLT3 and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 18, 2024 · Expires Jun 13, 2044

    granted
  12. US 11952429

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Apr 9, 2024 · Expires Apr 4, 2044

    granted
  13. US 11939377

    Affinity matured CD22-specific monoclonal antibody and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  14. US 11896654

    DNA monoclonal antibodies targeting checkpoint molecules

    Inovio Pharmaceuticals, Inc. · Granted Feb 13, 2024 · Expires Feb 8, 2044

    granted
  15. US 11891436

    Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)

    Julius-Maximilians-Universitat Wurzburg · Granted Feb 6, 2024 · Expires Feb 1, 2044

    granted
  16. US 11884718

    Potent zika virus-specific and cross-neutralizing monoclonal antibodies to zika and dengue viruses following ZIKV infection or vaccination

    The Government of the United States, as represented by the Secretary of the Army · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted
  17. US 11866503

    Methods for treating inflammatory conditions of the airway or lungs by administering antagonist monoclonal antibodies to interleukin-33 and interleukin-4 receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  18. US 11851477

    DNA monoclonal antibodies targeting influenza virus

    Inovio Pharmaceuticals, Inc. · Granted Dec 26, 2023 · Expires Dec 21, 2043

    granted
  19. US 11767367

    Monoclonal antibody neo-201 for the treatment of human carcinomas

    PRECISION BIOLOGICS, INC. · Granted Sep 26, 2023 · Expires Sep 21, 2043

    granted
  20. US 11760795

    Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer

    Julius-Maximilians-Universitat Wurzburg · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted
  21. US 11680093

    Monoclonal antibodies that specifically bind to matrilin 3 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  22. US 11673966

    Monoclonal and humanized antibodies to a cancer glycopeptide

    The Board of Regents of the University of Texas System · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  23. US 11634482

    Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer

    Julius-Maximilians-Universitat Wurzburg · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted
  24. US 11572413

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted